e-learning
resources
London 2016
Sunday, 04.09.2016
Latest insights into functional capacity and muscle weakness in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The anti-inflammatory effects of aerobic exercise in asthma is mediated by purinergic signaling
Manoel Carneiro de Oliveira Jr (São Paulo, Brazil), Manoel Carneiro de Oliveira Jr, Alana dos Santos Dias, Nicole Cristine Rigonato Oliveira, Auriléia Aparecida Brito, Erasmo Assumpção Neto, Elias El Mafarjeh, Nilsa Regina Damaceno Rodrigues, Marco Idzko, Ana Paula Ligeiro de Oliveira, Rodolfo de Paula Vieira
Source:
International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Session:
Latest insights into functional capacity and muscle weakness in chronic lung diseases
Session type:
Thematic Poster
Number:
698
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Manoel Carneiro de Oliveira Jr (São Paulo, Brazil), Manoel Carneiro de Oliveira Jr, Alana dos Santos Dias, Nicole Cristine Rigonato Oliveira, Auriléia Aparecida Brito, Erasmo Assumpção Neto, Elias El Mafarjeh, Nilsa Regina Damaceno Rodrigues, Marco Idzko, Ana Paula Ligeiro de Oliveira, Rodolfo de Paula Vieira. The anti-inflammatory effects of aerobic exercise in asthma is mediated by purinergic signaling. Eur Respir J 2016; 48: Suppl. 60, 698
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Anti-inflammatory effects of aerobic exercise in a murine model of asthma: Role of leukotrienes pathway
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Leukotrienes pathway are involved in the anti-inflammatory effects aerobic exercise on asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Aerobic exercise reduces asthma phenotype through inhibition of SOCS-JAK-STAT signaling in airway epithelium
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Aerobic exercise reduces asthma phenotype by inhibition of JAK2, SOCS3 and STAT6 in airway epithelium and in peribronchial leukocytes
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Mechanisms underlying the role of exercise training as part of a weight loss program on asthma control in obese asthmatics
Source: International Congress 2016 – Effects of exercise training interventions in chronic respiratory disease
Year: 2016
Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Exercise induced broncho-constriction: from mechanism to clinical effects
Source: Annual Congress 2013 –New ATS/ERS recommendations for bronchial challenge testing
Year: 2013
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Autonomic dysregulation; a mechanism of asthma death
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
The effect of oligomeric proanthocyanidin on airway microenvironment in asthma
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept